{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T18:33:01Z","timestamp":1715452381718},"reference-count":26,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_raon-2015-0033_s_333_w2aab3b8c23b1b7b1aab1c15b1Aa\">\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Sarcoidosis before and after treatment of malignancy is an important differential diagnosis that has to be distinguished from lymphoma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_raon-2015-0033_s_334_w2aab3b8c23b1b7b1aab1c15b2Aa\">\n                  <jats:title>Patients and methods<\/jats:title>\n                  <jats:p>Hodgkin lymphoma, diffuse large B-cell lymphoma and aggressive follicular lymphoma are being staged and treatment effect is evaluated with PET-CT. We report three cases of aggressive lymphoma after high dose therapy and autologous stem cell transplantation with positive lymph nodes on PET-CT, which were histologically diagnosed as sarcoidosis\/granulomatosis. In the literature, we found that false positive lymph nodes were more common after allogeneic than after autologous transplantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_raon-2015-0033_s_335_w2aab3b8c23b1b7b1aab1c15b3Aa\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Post-treatment PET-CT positive lymph nodes should always be examined histologically prior to any further treatment decision to avoid unnecessary toxic procedures.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/raon-2015-0033","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T20:14:44Z","timestamp":1439583284000},"page":"355-359","source":"Crossref","is-referenced-by-count":2,"title":["Granulomatosis after autologous stem cell transplantation in nonHodgkin lymphoma \u2013 experience of single institution and a review of literature"],"prefix":"10.1515","volume":"50","author":[{"given":"Lucka","family":"Boltezar","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Zagar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Institute of Oncology Ljubljana, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Jezersek","family":"Novakovic","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"2021040614325790672_j_raon-2015-0033_ref_001_w2aab3b8c23b1b7b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet 2014; 383: 1155-67.","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"2021040614325790672_j_raon-2015-0033_ref_002_w2aab3b8c23b1b7b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"Ulaner GA, Lilienstein J, G\u00f6nen M, Maragulia J, Moskowitz CH, Zelenetz AD. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. J Clin Oncol 2014; 32: 51-6.","DOI":"10.1200\/JCO.2013.50.8044"},{"key":"2021040614325790672_j_raon-2015-0033_ref_003_w2aab3b8c23b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol 2014; 32: 3048-58.","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"2021040614325790672_j_raon-2015-0033_ref_004_w2aab3b8c23b1b7b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, et al. Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 2013; 47: 103-10.","DOI":"10.2478\/raon-2013-0016"},{"key":"2021040614325790672_j_raon-2015-0033_ref_005_w2aab3b8c23b1b7b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin\u2019s lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001; 19: 414-9.","DOI":"10.1200\/JCO.2001.19.2.414"},{"key":"2021040614325790672_j_raon-2015-0033_ref_006_w2aab3b8c23b1b7b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"Spagnolo P, Luppi F, Roversi P, Cerri S, Fabbri LM, Richeldi L. Sarcoidosis: challenging diagnostic aspects of an old disease. Am J Med 2012; 125: 118-25.","DOI":"10.1016\/j.amjmed.2011.06.003"},{"key":"2021040614325790672_j_raon-2015-0033_ref_007_w2aab3b8c23b1b7b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Brady B, Kamel D, Kiely J, Hennessy B. Dual diagnosis of sarcoidosis and lymphoma. Ir J Med Sci 2013; 182: 283-6.","DOI":"10.1007\/s11845-012-0854-1"},{"key":"2021040614325790672_j_raon-2015-0033_ref_008_w2aab3b8c23b1b7b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"Han HS, Escal\u00f3n MP, Hsiao B, Serafini A, Lossos IS. High incidence of falsepositive PET scans in patients with aggressive non-Hodgkin\u2019s lymphoma treated with rituximab-containing regimens. Ann Oncol 2009; 20: 309-18.","DOI":"10.1093\/annonc\/mdn629"},{"key":"2021040614325790672_j_raon-2015-0033_ref_009_w2aab3b8c23b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Wholebody positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999; 94: 429-33.","DOI":"10.1182\/blood.V94.2.429"},{"key":"2021040614325790672_j_raon-2015-0033_ref_010_w2aab3b8c23b1b7b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"Naumann R, Vaic A, Beuthien-Baumann B, Bredow J, Kropp J, Kittner T, et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Br J Haematol 2001; 115: 793-800.","DOI":"10.1046\/j.1365-2141.2001.03147.x"},{"key":"2021040614325790672_j_raon-2015-0033_ref_011_w2aab3b8c23b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Gawande RS, Khurana A, Messing S, Zhang D, Castaneda RT, Goldsby RE, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET\/CT. Radiology 2012; 262: 613-22.","DOI":"10.1148\/radiol.11110715"},{"key":"2021040614325790672_j_raon-2015-0033_ref_012_w2aab3b8c23b1b7b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Suen JS, Forse MS, Hyland RH, Chan CK. The malignancy-sarcoidosis syndrome. Chest 1990; 98: 1300-2.","DOI":"10.1378\/chest.98.5.1300"},{"key":"2021040614325790672_j_raon-2015-0033_ref_013_w2aab3b8c23b1b7b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Kornacker M, Kraemer A, Leo E, Ho AD. Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin\u2019s lymphoma: report of two cases. Ann Hematol 2002; 81: 103-5.","DOI":"10.1007\/s00277-001-0415-6"},{"key":"2021040614325790672_j_raon-2015-0033_ref_014_w2aab3b8c23b1b7b1ab2ac14Aa","unstructured":"Fishman JA. Approach to the immunocompromised patient with fever and pulmonary infiltrates. In: Marr KA, Thorner AR, editors. Uptodate.com. UpToDate; C 2013 [citated 2014 Oct 19]. Available from: http:\/\/www.uptodate.com\/"},{"key":"2021040614325790672_j_raon-2015-0033_ref_015_w2aab3b8c23b1b7b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974; 29: 24-52.","DOI":"10.1038\/bjc.1974.64"},{"key":"2021040614325790672_j_raon-2015-0033_ref_016_w2aab3b8c23b1b7b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"Brincker H. The sarcoidosis-lymphoma-syndrome. Br J Cancer 1986; 54: 467-73.","DOI":"10.1038\/bjc.1986.199"},{"key":"2021040614325790672_j_raon-2015-0033_ref_017_w2aab3b8c23b1b7b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"Inoue K, Goto R, Shimomura H, Fukuda H. FDG-PET\/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment. Springerplus 2013; 2: 113.","DOI":"10.1186\/2193-1801-2-113"},{"key":"2021040614325790672_j_raon-2015-0033_ref_018_w2aab3b8c23b1b7b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol 2007; 25: 326-33.","DOI":"10.1016\/j.clindermatol.2007.03.010"},{"key":"2021040614325790672_j_raon-2015-0033_ref_019_w2aab3b8c23b1b7b1ab2ac19Aa","doi-asserted-by":"crossref","unstructured":"Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET\/CT: prevalence and disease pattern. Clin Radiol 2009; 64: 675-81.","DOI":"10.1016\/j.crad.2009.03.005"},{"key":"2021040614325790672_j_raon-2015-0033_ref_020_w2aab3b8c23b1b7b1ab2ac20Aa","doi-asserted-by":"crossref","unstructured":"Hunsaker AR, Munden RF, Pugatch RD, Mentzer SJ. Sarcoidlike reaction in patients with malignancy. Radiology 1996; 200: 255-61.","DOI":"10.1148\/radiology.200.1.8657922"},{"key":"2021040614325790672_j_raon-2015-0033_ref_021_w2aab3b8c23b1b7b1ab2ac21Aa","doi-asserted-by":"crossref","unstructured":"Hunt BM, Valli\u00e8res E, Buduhan G, Aye R, Louie B. Sarcoidosis as a benign cause of lymphadenopathy in cancer patients. Am J Surg 2009; 197: 629-32.","DOI":"10.1016\/j.amjsurg.2009.01.004"},{"key":"2021040614325790672_j_raon-2015-0033_ref_022_w2aab3b8c23b1b7b1ab2ac22Aa","doi-asserted-by":"crossref","unstructured":"Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev 1986; 13: 147-56.","DOI":"10.1016\/0305-7372(86)90002-2"},{"key":"2021040614325790672_j_raon-2015-0033_ref_023_w2aab3b8c23b1b7b1ab2ac23Aa","doi-asserted-by":"crossref","unstructured":"Haran MZ, Feldberg E, Berrebi A. Lymphoma masking sarcoidosis. Leuk Lymphoma 2002; 43: 1709-10.","DOI":"10.1080\/1042819021000003090"},{"key":"2021040614325790672_j_raon-2015-0033_ref_024_w2aab3b8c23b1b7b1ab2ac24Aa","doi-asserted-by":"crossref","unstructured":"Merchant TE, Filippa DA, Yahalom J. Sarcoidosis following chemotherapy for Hodgkin\u2019s disease. Leuk Lymphoma 1994; 13: 339-47.","DOI":"10.3109\/10428199409056299"},{"key":"2021040614325790672_j_raon-2015-0033_ref_025_w2aab3b8c23b1b7b1ab2ac25Aa","doi-asserted-by":"crossref","unstructured":"Kim MH, Lee K, Kim KU, Park HK, Lee MK, Suh DS. Sarcoidosis mimicking cancer metastasis following chemotherapy for ovarian cancer. Cancer Res Treat 2013; 45: 354-8.","DOI":"10.4143\/crt.2013.45.4.354"},{"key":"2021040614325790672_j_raon-2015-0033_ref_026_w2aab3b8c23b1b7b1ab2ac26Aa","doi-asserted-by":"crossref","unstructured":"Torchio M, Bottaro G, Bertolino G, Comolli G, Bello BD, Invernizzi R, et al. Late-onset sarcoidosis in a patient with gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma: A case report. Oncol Lett 2014; 8: 1299-301.","DOI":"10.3892\/ol.2014.2241"}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/raon\/50\/4\/article-p355.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/raon-2015-0033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T21:24:08Z","timestamp":1617744248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/raon-2015-0033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,11,9]]},"published-print":{"date-parts":[[2016,12,1]]}},"alternative-id":["10.1515\/raon-2015-0033"],"URL":"https:\/\/doi.org\/10.1515\/raon-2015-0033","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}